Stan Rowe's guest appearances

Stan Rowe

Medtech Talk

DeviceAlliance: MedTech Radio

Education evolution

HiPERleadership

Scott Whitaker

Jeff Ross

Scott Anderson

Jeff Blanton

David Powell

Travis Smith

Anne Morrissey

Nicole Walker

Patrick Johnson

Todd Pope

Jeffrey Brewer

Harry Rowland

Bob Paulson

Steve Charles

Jim Mazzo

OwlTail

Deerfield Management and Stan Rowe created a therapeutic device incubator, NXT Biomedical.  NXT Biomedical expects to invest up to $25 million in cutting edge technologies over the next 5 years.  Deerfield has allotted up to an additional $250 million for the formation and development of five to eight startup companies that emerge from the incubator.  NXT Biomedical provides an exciting new pathway for exceptional science to be incubated with the world-renowned leadership while continuing to address major unmet needs with next-generation medical technologies. In this episode of DeviceAlliance’s Medtech Radio, we speak with the Co-Founder &amp; CEO of NXT Biomedical, Stan Rowe.  Stan recently retired from Edwards Lifesciences where he was Chief Scientific Officer since 2008 and also served as Corporate Vice President, Advanced Technology.  He joined in 2004 when Edwards acquired Percutaneous Valve Technologies, a company he helped to found in 1999 and served as President and CEO.  Join us as we discuss Stan's life lessons learned in the Medtech industry, including... - What are the biggest mistakes R&amp;D makes - Growing a company in his bedroom to being acquired - Biggest strategic considerations for innovation - Different types of accelerators - Addressing the future of unmet clinical needs

Deerfield Management and Stan Rowe created a therapeutic device incubator, NXT Biomedical.  NXT Biomedical expects to invest up to $25 million in cutting edge technologies over the next 5 years.  Deerfield has allotted up to an additional $250 million for the formation and development of five to eight startup companies that emerge from the incubator.  NXT Biomedical provides an exciting new pathway for exceptional science to be incubated with the world-renowned leadership while continuing to address major unmet needs with next-generation medical technologies. In this episode of DeviceAlliance’s Medtech Radio, we speak with the Co-Founder &amp; CEO of NXT Biomedical, Stan Rowe.  Stan recently retired from Edwards Lifesciences where he was Chief Scientific Officer since 2008 and also served as Corporate Vice President, Advanced Technology.  He joined in 2004 when Edwards acquired Percutaneous Valve Technologies, a company he helped to found in 1999 and served as President and CEO.  Join us as we discuss Stan's life lessons learned in the Medtech industry, including... - What are the biggest mistakes R&amp;D makes - Growing a company in his bedroom to being acquired - Biggest strategic considerations for innovation - Different types of accelerators - Addressing the future of unmet clinical needs

Stan Rowe: The Three Legged Stool | Ep.37

Matt interviews Stan Rowe of NXT Biomedical. Stan is an ex-executive at Edwards Lifesciences and has moved on to start his own MedTech incubator headquartered in Irvine, CA.

Interview with Stan Rowe, CEO of NXT Biomedical

After leading a long, distinguished and successful career in Medtech Innovation, Stan Rowe chose a familiar, if not unusual, spot to “retire” – he co-founded NXT Biomedical, an incubator backed by Deerfield Capital and Johnson &amp; Johnson. Rowe previously led the unique Advanced Technologies Unit at Edwards Lifesciences Corp., the same company that earlier had acquired his start-up, Percutaneous Valve Technologies. In this podcast, Rowe walks us through a career that started in pharmaceuticals. He also shares his particular philosophy on how corporate R&amp;D units should see the world.

After leading a long, distinguished and successful career in Medtech Innovation, Stan Rowe chose a familiar, if not unusual, spot to “retire” – he co-founded NXT Biomedical, an incubator backed by Deerfield Capital and Johnson &amp; Johnson. Rowe previously led the unique Advanced Technologies Unit at Edwards Lifesciences Corp., the same company that earlier had acquired his start-up, Percutaneous Valve Technologies. In this podcast, Rowe walks us through a career that started in pharmaceuticals. He also shares his particular philosophy on how corporate R&amp;D units should see the world.

Medtech Incubator NXT Biomedical Shows Stan Rowe Is Great at Innovation, Bad at “Retirement”